You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Intrinsic Value | Fundamental Analysis

Returns | 1W : -2.4% , 1M : 1.4%,1Y : 9.5%
https://www.pghealthindia.com
BOM : 500126     NSE : PGHL    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Oct 18,2021
Price(EOD): Rs. 5,565.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Affiliate Link.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
PROCTER & GAMBLE HEALTH -2.4% 1.4% 9.5%
SUN PHARMACEUTICAL INDUSTRIES 0.3% 7% 67.1%
DIVIS LABORATORIES 3.8% 3.4% 70.9%
DR REDDYS LABORATORIES -0.4% -1.2% -4%
CIPLA -1.1% -5.3% 15.6%
GLAND PHARMA -1.6% -7.1% NA
PIRAMAL ENTERPRISES 2.3% 6.4% 121.8%
CADILA HEALTHCARE -2.5% -5.3% 26.5%
TORRENT PHARMACEUTICALS -1.8% -0% 11.4%


FUNDAMENTAL ANALYSIS OF PROCTER & GAMBLE HEALTH

 
Fundamentals Score
[ Q(TTM): Jun2021, Y: Jun2020
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than PROCTER & GAMBLE HEALTH Plus/Pro


VALUATION OF PROCTER & GAMBLE HEALTH

 
Valuation Score
[As on : Oct 18,2021 ]

Ratio Standalone
P/E
P/B
P/S
36.36
P/E Calculated based on EPS of 153.06
[ Jun2020 - Standalone Results ]

10.22
P/B Calculated based on Book Value of 544.82
[ Jun2020 - Standalone Results ]

9.16
P/S Calculated based on Revenues of 1008.73 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than PROCTER & GAMBLE HEALTH Plus/Pro


FAIR VALUE OF PROCTER & GAMBLE HEALTH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
272%
200%
190%

SHARE PRICE MOMENTUM OF PROCTER & GAMBLE HEALTH

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0
0.55
0
0.18
-
-
-
-
[Last Annual Data : Jun2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
30.23%
57.63%
66.78%
114.9%
41.88%
-8.76%
-21.89%
-30.64%
QtrlyTrend
2
Latest Qtr: Jun2021

PROCTER & GAMBLE HEALTH related INDICES

BSE Indices1W1M1Y
S&P BSE 400 MIDSMALLCAP 3.1% 7.2% 90.9%
S&P BSE 500 3% 5.2% 62%
S&P BSE ALLCAP 3% 5.3% 63.3%
S&P BSE MIDSMALLCAP 2.8% 6.4% 91.4%
S&P BSE SMALLCAP SELECT INDEX 2.3% 6.4% 92.6%
S&P BSE 250 SMALLCAP 2.2% 7.2% 97.4%
S&P BSE SMALL CAP 2% 6.3% 100.5%
S&P BSE HEALTHCARE -0.3% -2.3% 29.7%
NSE Indices1W1M1Y
NIFTY 500 3% 5.2% 61.8%
NIFTY MID SMALL400 2.9% 7.3% 90.4%
NIFTY500 MULTICAP 50:25:25 2.6% 5.5% NA
NIFTY SMALLCAP250 2.3% 7% 98.5%

You may also like the below Video Courses


FAQ [Frequently Asked Questions]


Is PROCTER & GAMBLE HEALTH good for long term investment?

As on 18-Oct-2021, the Fundamentals of PROCTER & GAMBLE HEALTH look Strong and hence it may be good for long term investment! See Financial Performance of PROCTER & GAMBLE HEALTH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is PROCTER & GAMBLE HEALTH UnderValued or OverValued?

As on 18-Oct-2021, PROCTER & GAMBLE HEALTH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of PROCTER & GAMBLE HEALTH ?

As on 18-Oct-2021, the Intrinsic Value of PROCTER & GAMBLE HEALTH is Rs. 1,857.17 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1,495.80
Fair Value [Median EV / Sales Model] : Rs. 1,857.17
Fair Value [Median Price / Sales Model] : Rs. 1,920.77
Median Fair Value of PROCTER & GAMBLE HEALTH : Rs. 1,857.17

Is PROCTER & GAMBLE HEALTH trading at a Premium or Discount?

As on 18-Oct-2021, PROCTER & GAMBLE HEALTH is trading at a Premium of 200% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of PROCTER & GAMBLE HEALTH ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of GLAND PHARMA LTD

What are the Frequent Comparisons in this Industry?

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z